Stocks in News Today - 7 Feb 2025

Stocks in News today - 7 feb 2025

a Asset Management (NAM India), asset manager of Nippon India Mutual Fund (NIMF), has launched Nippon India Active Momentum Fund an open-ended equity scheme that aims to generate long-term capital appreciation by investing in a diversified portfolio of equity and equity-related instruments. Nippon India Active Momentum Fund will employ a multi factor quantitative model aimed at identifying high-potential investment opportunities for long-term capital appreciation while managing volatility and adapting to market cycles. JNK India has received an order from JNK Global, Korea on February 6, 2025 for Residual Engineering, Procurement, Fabrication, Supply, and transportation till FOB (Mundra Port, India), and assistance on per diem basis for Erection, Commissioning, and witness of Performance Tests for Treating Heater, Isomerization Combined Feed Heater, and Product Fractionator Reboiler Heater for Pengerang Biorefinery Sdn. Bhd.’s Biorefinery project, Malaysia. The order is to be executed by April 9, 2026 (Delivery on FOB, Mundra Port). Equillium, Inc., and have announced positive topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ulcerative colitis (UC). The double-blinded, placebo- and active-controlled Phase 2 clinical study evaluated the safety and efficacy of itolizumab in biologic-naive patients with moderate to severe active UC. A total of 90 patients were randomized 1:1:1 to receive itolizumab (fixed dose of 140 mg), placebo, or adalimumab (a global standard of care biologic treatment used as an active control) every two weeks for an initial 12-week treatment period. Note : Make sure to follow risk management and position sizing at all times